Brief: PainReform Announces Positive Safety Data In First Part Of Phase 3 Clinical Trial Of PRF-110 In Patients Undergoing Bunionectomy Surgery

PRF Technologies

01/05/2023 13:42

May 1 (Reuters) - PainReform Ltd  PRFX.O :
    * PAINREFORM ANNOUNCES POSITIVE SAFETY DATA IN FIRST PART OF
PHASE
3 CLINICAL TRIAL OF PRF-110 IN PATIENTS UNDERGOING BUNIONECTOMY
SURGERY
    * PAINREFORM LTD - INITIAL RESULTS DEMONSTRATED A SOLID
SAFETY
PROFILE OF PRF-110
    * PAINREFORM LTD - TWENTY-SIX ADVERSE EVENTS (AES) WERE
RECORDED
IN TOTAL, WITH NO SERIOUS ADVERSE EVENTS (SAES) REPORTED
    * PAINREFORM LTD - ALL ADVERSE EVENTS WERE CONSIDERED MILD,
AND
MOST WERE DEEMED UNLIKELY TO BE RELATED TO PRF-110

Source text for Eikon:  ID:nGNXYWQvJ 
Further company coverage:  PRFX.O 

 ((Reuters.Briefs@thomsonreuters.com;))